Seegene on kehittänyt maailman ensimmäisen COVID-19-muunnostestin, jolla pystytään tunnistamaan virusmuunnosten alkuperä

SEEGENE TUO MARKKINOILLE ENSIMMÄISEN COVID-19-MUTAATIOIDEN TUNNISTUSTESTIN COVID-19-TESTIEN VALMISTAJA JATKAA MUUNNOSTEN SEURANTAA ETELÄ-KORELAINEN YRITYS, JOKA ON SITOUTUNUT YHTEISTYÖHÖN HALLITUSTEN KANSSA SOUL, Etelä-Korea, 19. huhtikuuta 2021 /PRNewswire/ -- Etelä-korealainen...

from PR Newswire: https://ift.tt/2RCosvM

Seegene aloittaa COVID-19 -varianttitestien viennin ympäri maailmaa auttaakseen hillitsemään pandemian leviämistä.

Seegene pystyy valmistamaan 300 000 muunnosdiagnoositestipakettia, joilla pystytään testaamaan 30 miljoonaa henkeä joka kuukausi. SOUL, Etelä-Korea, 19. maaliskuuta, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), molekyylidiagnostiikkaan erikoistunut bioteknologiayhtiö, ilmoitti tänään,...

from PR Newswire: https://ift.tt/3x6zZnu

2022 Lexus ES: The Quintessential Luxury Sedan Is Refreshed Inside And Out

PLANO, Texas, April 18, 2021 /PRNewswire/ -- In 2018, the all-new seventh-generation Lexus ES redefined its status among entry-level luxury sedans with a striking exterior design and transformative performance made possible by the Global Architecture–K (GA-K) platform. For the 2022 model...

from PR Newswire: https://ift.tt/3ehm6dB

Toyota Debuts All-Electric SUV Concept

PLANO, Texas, April 18, 2021 /PRNewswire/ -- Toyota envisions a future in which carbon neutrality is achieved through the practical marketization of a portfolio of products with advanced, alternative-fuel and zero-emission powertrain technologies. Already a leader in electrification, the...

from PR Newswire: https://ift.tt/2P0EOxv

Liquid now supports instant USD settlement on the Silvergate Exchange Network

SINGAPORE, April 18, 2021 /PRNewswire/ -- Liquid, one of the world's largest cryptocurrency-fiat exchange platforms by trade volume, is working with Silvergate Bank, a California-based Federal Reserve member bank, to improve market access and increase trading opportunities for Liquid's...

from PR Newswire: https://ift.tt/2QcJGA9

Transcenta Announced Successful First Patient Dosed in Phase I Clinical Study of TST001 Combined with CAPOX for the Treatment of Patients with First-line Locally Advanced Unresectable or Metastatic Gastric Cancer

SUZHOU, China, April 18, 2021 /PRNewswire/ -- Transcenta Holding Limited (Transcenta), a clinical stage global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, today announced the first patient has been...

from PR Newswire: https://ift.tt/3alU1Re

Sirnaomics Initiates Phase 2 Study Using STP705 for Keloid Scar Prevention

GAITHERSBURG, Md. and SUZHOU BIOBAY, China, April 18, 2021 /PRNewswire/ -- Sirnaomics, Inc., a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer and fibrotic diseases, today announced the initiation of a Phase 2 study of the company's...

from PR Newswire: https://ift.tt/3dsBvs5